BE of racemic drugs (EMA’s practice) [Regulatives / Guidelines]

posted by valivetiananth – India, 2019-12-30 14:45 (2357 d 08:29 ago) – Posting: # 21037
Views: 4,603

Dear Associate

Please update us the status of your query. same query was received from agency.

Regards
Valiveti


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
117 visitors (0 registered, 117 guests [including 19 identified bots]).
Forum time: 00:14 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5